BusinessSummit Highlights Discovery of a Series of New Mechanism Antibiotics for the Treatment of Gonorrhoea in Late-Breaking Presentation at ECCMID 2018By Nasdaq OMXApr 23, 2018, 11:00 AM UTC
BusinessECCMID Presentation to Demonstrate Revolutionary Breakthrough in Malaria DetectionBy Nasdaq OMXApr 17, 2017, 9:30 AM UTC
BusinessPositive Results From Summit's Phase 2 CoDIFy Trial Highlight Potential of Ridinilazole in the Treatment of C. difficile InfectionBy Nasdaq OMXApr 11, 2016, 11:00 AM UTC
BusinessSummit to Present Additional Data From Phase 2 CoDIFy Trial Showing Ridinilazole’s Statistical Superiority Over Vancomycin in Sustained Clinical Response was Driven by Marked Reduction in Recurrence of C. difficile InfectionBy Nasdaq OMXMar 29, 2016, 1:25 PM UTC
